Head and Neck Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Head and Neck Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer [Phase 2]
Phase 2 trial evaluating nab-paclitaxel and carboplatin followed by response-based local therapy for HPV-related oropharyngeal cancer (Stage…
-
CLINICAL_TRIALS trial_result · 2020-12-23Clinical Trial Update: Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]
Phase 1/2 study of an HPV-specific immunotherapy in participants with HPV-associated head and neck squamous cell carcinoma completed; result…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study [Phase 2]
A Phase 2 follow-up study reports results on de-intensifying radiation with chemotherapy for low-risk HPV-related oropharyngeal squamous cel…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck Cancer [Phase 2]
Phase 2 trial update evaluating Genexol-PM with cisplatin in locally advanced head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-03Clinical Trial Update: Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating abemaciclib with nivolumab in recurrent/metastatic head and neck squamous cell carcinoma that progressed after pl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pembrolizumab in combination with vorinostat for recurrent, metastatic, or unresectable squamous cell ca…
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma [Phase 2]
Phase 2 clinical trial evaluating phonosurgical augmentation after laser resection for early glottic carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck [Phase 2]
Phase 2 clinical trial evaluating postoperative concurrent chemoradiotherapy with docetaxel for high-risk squamous cell carcinoma of the hea…
-
CLINICAL_TRIALS trial_result · 2020-08-07Clinical Trial Update: Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC. [Phase 4]
Phase 4 trial update comparing radiotherapy with or without raltitrexed in older patients with head and neck squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 1]
Phase 1 dose-finding trial evaluating metformin in combination with chemoradiation for locally advanced head and neck squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2020-05-27Clinical Trial Update: SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update for SCT200 plus platinum-based chemotherapy in head and neck squamous cell carcinoma (HNSCC).
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: Phase II Study for Combination of Camrelizumab and SBRT in the First-line Treatment for R/M HNSCC [Phase 2]
A Phase II trial evaluating the combination of camrelizumab and stereotactic body radiotherapy (SBRT) as first-line treatment for recurrent/…
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux [Phase 3]
Phase 3 randomized trial evaluating concomitant chemotherapy with radiotherapy and cetuximab (Erbitux) in locally advanced head and neck squ…
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update for BB-401 in recurrent or metastatic head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of TAK-659 in combination with nivolumab in advanced solid tumors was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Preoperative Treatment With Cetuximab and/or IMC-A12 [Phase 2]
Phase 2 trial update examining preoperative treatment with cetuximab and/or IMC-A12 in head and neck squamous cell carcinoma; study complete…
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract [Phase 2]
A Phase II trial evaluating tadalafil in patients with head and neck squamous cell carcinoma has completed recruitment; results have been po…
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. [Phase 1, Phase 2]
Phase 1b/Phase 2 clinical trial evaluating food-based modulation of biomarkers in tissues from individuals at high risk for oral cancer has …
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) [Phase 3]
A Phase 3 trial (KEYNOTE-048) evaluated pembrolizumab as first-line therapy for recurrent or metastatic head and neck squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck. [Phase 2]
Phase 2 clinical trial evaluating preoperative olaparib with cisplatin, with durvalumab, or alone (or no treatment) in patients planned for …
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma [Phase 3]
Phase 3 clinical trial update for SCT-I10A plus standard chemotherapy in first-line recurrent/metastatic head and neck squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy [Phase 2]
Phase 2 trial evaluating epacadostat with pembrolizumab in head and neck cancer that progressed after prior immunotherapy; study terminated …
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial update examining safety and efficacy of SCT-I10A in head and neck squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer [EARLY_Phase 1]
A completed early-phase trial tested metformin hydrochloride for effects on cytokines and exosomes in patients with head and neck cancers, i…
-
CLINICAL_TRIALS trial_result · 2019-11-15Clinical Trial Update: Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 3]
Phase 3 study evaluating chemotherapy with or without bevacizumab for recurrent or metastatic head and neck squamous cell carcinoma; results…